Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maliepaard

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Netherlands Journal of Medicine|February 23, 2008
Generics: what is the role of registration authoritiesC Versantvoort, M Maliepaard, F Lekkerkerker
ESMO Open|November 9, 2021
Dose selection and tolerability of anticancer agents evaluated by the European Medicines Agency in the period 2015-2020M Maliepaard, W Carree, M T J van Bussel
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Modeling and simulation in clinical pharmacology and dose findingA Staab, E Rook, M Maliepaard, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1J Ma, M Maliepaard, H J Kolker, et al.
Clinical Pharmacology and Therapeutics|May 28, 2013
Interchangeability of gabapentin generic formulations in the Netherlands: a comparative bioavailability studyY Yu, S Teerenstra, F Vanmolkot, et al.
Analytical Biochemistry|November 5, 1999
32P-postlabeling assay for the quantification of the major platinum-DNA adductsD Pluim, M Maliepaard, R C van Waardenburg, et al.
British Journal of Cancer|April 1, 1995
Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidaseM Maliepaard, A Wolfs, S E Groot, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitroJ Ma, M Maliepaard, K Nooter, et al.
Biochimica Et Biophysica Acta|November 14, 1990
Comparable interaction of doxorubicin with various acidic phospholipids results in changes of lipid order and dynamicsF A de Wolf, M Maliepaard, F van Dorsten, et al.
British Journal of Haematology|November 13, 2001
Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemiaJ M Sargent, C J Williamson, M Maliepaard, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Netherlands Journal of Medicine|February 23, 2008
Generics: what is the role of registration authoritiesC Versantvoort, M Maliepaard, F Lekkerkerker
ESMO Open|November 9, 2021
Dose selection and tolerability of anticancer agents evaluated by the European Medicines Agency in the period 2015-2020M Maliepaard, W Carree, M T J van Bussel
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Modeling and simulation in clinical pharmacology and dose findingA Staab, E Rook, M Maliepaard, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1J Ma, M Maliepaard, H J Kolker, et al.
Clinical Pharmacology and Therapeutics|May 28, 2013
Interchangeability of gabapentin generic formulations in the Netherlands: a comparative bioavailability studyY Yu, S Teerenstra, F Vanmolkot, et al.
Analytical Biochemistry|November 5, 1999
32P-postlabeling assay for the quantification of the major platinum-DNA adductsD Pluim, M Maliepaard, R C van Waardenburg, et al.
British Journal of Cancer|April 1, 1995
Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidaseM Maliepaard, A Wolfs, S E Groot, et al.
Cancer Chemotherapy and Pharmacology|March 6, 1998
Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitroJ Ma, M Maliepaard, K Nooter, et al.
Biochimica Et Biophysica Acta|November 14, 1990
Comparable interaction of doxorubicin with various acidic phospholipids results in changes of lipid order and dynamicsF A de Wolf, M Maliepaard, F van Dorsten, et al.
British Journal of Haematology|November 13, 2001
Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemiaJ M Sargent, C J Williamson, M Maliepaard, et al.
Pageof 4